search
Back to results

Colorectal Cancer Screnning Colonoscopy Under Hypnosis (CODEPICCH)

Primary Purpose

Colorectal (Colon or Rectal) Cancer

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Colonoscopy under hypnosis
Sponsored by
University Hospital, Tours
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Colorectal (Colon or Rectal) Cancer

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients 18 years of age or older
  • Undergoing a screening colonoscopy (mass screening Fecal Immunochemical Test positive or as an individual (family history of colon cancer or adenoma, personal history of adenoma, cancer, chronic inflammatory bowel disease) or in the context of a transit disorder, hemorrhage or anemia
  • Affiliated with a French social security system
  • Having signed a written consent

Exclusion Criteria:

  • Patient requiring emergency colonoscopy
  • History of colonic resection
  • Carriers of behavioral disorders and/or psychiatric illness
  • Limited cognitive abilities making it impossible to read or fill out a discrete choice questionnaire (language problems, comprehension problems)
  • Contraindication to hypnosis, preventing quality interaction (comprehension and/or language problems, hearing impairment)
  • Contraindication to general anesthesia
  • Under a legal protection regime
  • Pregnant or breastfeeding woman

Sites / Locations

  • Chu AngersRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Hypnosis

General anesthesia

Arm Description

Common practice

Outcomes

Primary Outcome Measures

Rate of complete colonoscopies
Rate of complete colonoscopies: a colonoscopy is said to be complete when the endoscopist visualizes the caecal fundus.

Secondary Outcome Measures

Level of anxiety
Level of anxiety is measured by the State-Trait Anxiety Inventory (Form Y) scale
Level of pain
pain level measured by self-evaluation via a visual analog scale between 0 and 10 cm, at the consultation, before and after the colonoscopy in both groups and during the procedure, before returning to the room only in the Hypnosis group. The doctor will present the ungraded side of the VAS to the patient and ask him/her to place the cursor on the maximum pain intensity felt during the procedure.
Level of pain
pain level measured by self-evaluation via a visual analog scale between 0 and 10 cm, at the consultation, before and after the colonoscopy in both groups and during the procedure, before returning to the room only in the Hypnosis group. The doctor will present the ungraded side of the VAS to the patient and ask him/her to place the cursor on the maximum pain intensity felt during the procedure.
Duration of colonoscopy
Duration of the endoscopy measured in minutes, distinguishing between: the time between the introduction of the endoscope into the anus and its arrival at the caecal floor and the time required in the opposite direction. The time taken to remove the polyps will be counted.
Rate of polyps resected
compare the rate of resected polyps between the two groups
Rate of complications
Rate of complications within 8 days post-colonoscopy (perforation, bleeding, inhalation pneumonitis, ...). Patients will be instructed to call back the service in case of complications
Patient satisfaction
Patient satisfaction questionnaire regarding the different stages of their care as well as their future wishes regarding the procedure to be considered in the event of a new colonoscopy. The satisfaction questionnaire will focus on the patient's experience of the management on arrival, the set-up in the examination room and the procedure. The best way to verify patient satisfaction is to ask the patient if he or she would like the next colonoscopy to be done under the same conditions.
Medico economic criteria
Proportion of pairs (Δ cost, Δ effect) belonging to the non-inferiority area in the incremental cost-effectiveness design, for different values of the economic non-inferiority margin and at constant value of the clinical non-inferiority margin (5%).

Full Information

First Posted
July 20, 2021
Last Updated
June 14, 2023
Sponsor
University Hospital, Tours
search

1. Study Identification

Unique Protocol Identification Number
NCT05051046
Brief Title
Colorectal Cancer Screnning Colonoscopy Under Hypnosis
Acronym
CODEPICCH
Official Title
Colorectal Cancer Screnning Colonoscopy Under Hypnosis: A Multicenter Randomized Non-Inferiority Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 31, 2022 (Actual)
Primary Completion Date
February 8, 2025 (Anticipated)
Study Completion Date
February 8, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Tours

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Through this study, the effectiveness of hypnosis in the realization of a colonoscopy for the detection of colorectal cancer will be evaluated
Detailed Description
Colorectal cancer is the 3rd most common cancer. Colonoscopy, a screening examination, has led to an increase in patient survival. In more than 90% of cases, this examination is performed under general anesthesia (GA) because it is considered painful, even though several studies have shown its feasibility without GA with a good tolerance in 75% of cases. However, only 28% of patients accept the examination without GA because of great apprehension. GA entails an increased risk of complications but also additional costs. Thus, performing colonoscopies without GA would reduce risks and costs by 15 to 30%. In order to make the examination more acceptable and less anxiety-provoking, methods such as hypnosis have been tested with the result that pain and anxiety are reduced and the hemodynamic state of the patients is stabilized, thus reducing the examination time. To date, the majority of studies on hypnosis, of varying indications, are small, mono-centric and non-randomized. The use of hypnosis for colorectal cancer screening colonoscopies would reduce patient anxiety, avoid complications related to GA and reduce the organizational constraints and costs related to GA.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal (Colon or Rectal) Cancer

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Hypnosis
Arm Type
Experimental
Arm Title
General anesthesia
Arm Type
No Intervention
Arm Description
Common practice
Intervention Type
Procedure
Intervention Name(s)
Colonoscopy under hypnosis
Intervention Description
The hypnosis used will be of the Ericksonian type. Before the colonoscopy begins, the IDE puts the patient in a hypnotic situation.
Primary Outcome Measure Information:
Title
Rate of complete colonoscopies
Description
Rate of complete colonoscopies: a colonoscopy is said to be complete when the endoscopist visualizes the caecal fundus.
Time Frame
The day of the colonoscopy, from the start to the end of the colonoscopy
Secondary Outcome Measure Information:
Title
Level of anxiety
Description
Level of anxiety is measured by the State-Trait Anxiety Inventory (Form Y) scale
Time Frame
The day of the colonoscopy, before the exam
Title
Level of pain
Description
pain level measured by self-evaluation via a visual analog scale between 0 and 10 cm, at the consultation, before and after the colonoscopy in both groups and during the procedure, before returning to the room only in the Hypnosis group. The doctor will present the ungraded side of the VAS to the patient and ask him/her to place the cursor on the maximum pain intensity felt during the procedure.
Time Frame
During the consultation before the colonoscopy
Title
Level of pain
Description
pain level measured by self-evaluation via a visual analog scale between 0 and 10 cm, at the consultation, before and after the colonoscopy in both groups and during the procedure, before returning to the room only in the Hypnosis group. The doctor will present the ungraded side of the VAS to the patient and ask him/her to place the cursor on the maximum pain intensity felt during the procedure.
Time Frame
Up to 24 hours the day of colonoscopy
Title
Duration of colonoscopy
Description
Duration of the endoscopy measured in minutes, distinguishing between: the time between the introduction of the endoscope into the anus and its arrival at the caecal floor and the time required in the opposite direction. The time taken to remove the polyps will be counted.
Time Frame
The day of colonoscopy from the start to the end of the exam
Title
Rate of polyps resected
Description
compare the rate of resected polyps between the two groups
Time Frame
The day of colonoscopy from the start to the end of the exam
Title
Rate of complications
Description
Rate of complications within 8 days post-colonoscopy (perforation, bleeding, inhalation pneumonitis, ...). Patients will be instructed to call back the service in case of complications
Time Frame
To the day of the exam to 8 days after
Title
Patient satisfaction
Description
Patient satisfaction questionnaire regarding the different stages of their care as well as their future wishes regarding the procedure to be considered in the event of a new colonoscopy. The satisfaction questionnaire will focus on the patient's experience of the management on arrival, the set-up in the examination room and the procedure. The best way to verify patient satisfaction is to ask the patient if he or she would like the next colonoscopy to be done under the same conditions.
Time Frame
Up to 24 hours the day of the colonoscopy
Title
Medico economic criteria
Description
Proportion of pairs (Δ cost, Δ effect) belonging to the non-inferiority area in the incremental cost-effectiveness design, for different values of the economic non-inferiority margin and at constant value of the clinical non-inferiority margin (5%).
Time Frame
To the day of the exam to 3 months after

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients 18 years of age or older Undergoing a screening colonoscopy (mass screening Fecal Immunochemical Test positive or as an individual (family history of colon cancer or adenoma, personal history of adenoma, cancer, chronic inflammatory bowel disease) or in the context of a transit disorder, hemorrhage or anemia Affiliated with a French social security system Having signed a written consent Exclusion Criteria: Patient requiring emergency colonoscopy History of colonic resection Carriers of behavioral disorders and/or psychiatric illness Limited cognitive abilities making it impossible to read or fill out a discrete choice questionnaire (language problems, comprehension problems) Contraindication to hypnosis, preventing quality interaction (comprehension and/or language problems, hearing impairment) Contraindication to general anesthesia Under a legal protection regime Pregnant or breastfeeding woman
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Driffa MOUSSATA, PhD
Phone
+33 2 47 47 83 50
Email
D.MOUSSATA@chu-tours.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Elodie MOUSSET
Phone
+33 2 47 47 46 65
Email
e.mousset@chu-tours.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Driffa MOUSSATA, PhD
Organizational Affiliation
University Hospital Center of Tours
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chu Angers
City
Angers
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Elodie METIVIER
Email
Elmetiviercesbron@chu-angers.fr

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Colorectal Cancer Screnning Colonoscopy Under Hypnosis

We'll reach out to this number within 24 hrs